您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb (S-1146-117)

Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb (S-1146-117)

货号: S0B1284
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Phospho-NF-κB p105 (Ser932)
  • 分子别名

    Nuclear factor NF-kappa-B p105 subunit; DNA-binding factor KBF1; EBP-1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    P19838
  • 克隆号

    S-1146-117
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    WB
  • 反应种属 ?

    Ms, Rt
  • 预测反应种属
    (反应种属缩写表)

    Dg
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度 推荐种属
WB 1:1000 Ms, Rt
背景介绍
  • Phospho-NF-κB p105 (Ser932) refers to the phosphorylated form of the NF-κB p105 protein at the serine residue 932. This post-translational modification is significant as it triggers a series of events that lead to the activation of the NF-κB signaling pathway, which is crucial in regulating immune and inflammatory responses. When p105 is phosphorylated at Ser932 by the IKK complex, it recruits the SCFβTrCP E3 ligase, leading to the ubiquitination and subsequent proteasomal degradation of p105. This degradation releases the active form of TPL-2, which in turn activates the MEK/ERK signaling pathway. Therefore, phosphorylation at Ser932 is a key regulatory step in controlling NF-κB activation and MAP kinase signaling, which coordinate the functions of lymphocytes and macrophages in the immune response.

  • 免疫印迹

    • WB result of Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb
      Primary antibody: Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated NIH/3T3 whole cell lysate 20 µg
      Lane 2: NIH/3T3 treated with 20 ng/ml TNF-α for 10 minutes and 100 nM Calyculin A for 10 minutes whole cell lysate 20 µg
      Lane 3: NIH/3T3 treated with 20 ng/ml TNF-α for 10 minutes and 100 nM Calyculin A for 10 minutes, then treated with phosphatase whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 105 kDa
      Observed MW: 110 kDa

    • WB result of Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb
      Primary antibody: Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated C6 whole cell lysate 20 µg
      Lane 2: C6 treated with 100 nM Calyculin A for 30 minutes whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 105 kDa
      Observed MW: 110 kDa